Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - dexmedetomidine

Malta - English - Malta Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for injection/infusion - rocuronium bromide 10 mg/ml - muscle relaxants

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ondansetron hydrochloride dihydrate - solution for infusion - ondansetron

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ondansetron hydrochloride dihydrate - solution for infusion - ondansetron

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - fresenius extension asv y bcv syringe pump infusion line is single use connecting lines for extension of infusion and transfusion sets, for use with pressure infusion equipment.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - moxifloxacin - solution for infusion - 400/250 milligram(s)/millilitre - fluoroquinolones; moxifloxacin

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows